athira.com (ATHA) - Uzoq muddatli majburiyatlarning kapitalga nisbati
Athira Pharma, Inc. (ATHA) demensiya uchun noyob miya regeneratsiyasi usullarini ishlab chiqmoqda, bu esa uzoq muddatli qarzning kapitalga nisbati bilan qo'llab-quvvatlanadi. 0.02 ning joriy qiymati ushbu metrikaning darajasini aks ettiradi. Neyrobiologlarning barqaror shtati va FDA tartibga soluvchi ishlari bo'yicha tajriba mahsulot ishlab chiqilishini kafolatlaydi. Shu bilan birga, Altsgeymer molekulalari uchun patent himoyasi kompaniya uchun barqaror marjalar va ko'p yillik talabni ta'minlaydi.
&width=1200&height=400&colorIndex=0&v=mvvwvvs9.gq-7b28iyo&start=20220704&end=20261031&filename=GURU_Markets_-_ATHA_-_Athira-Pharma-Inc._-_Long-Term-Debt-to-Equity-Ratio "ATHA - Athira Pharma Uzoq muddatli qarzning kapitalga nisbati 04.07.2022 - 12.01.2026 oraligʻida | 👁️GURU.Markets👁️")
Athira Pharma, Inc. (ATHA) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- bozor kapitallashuvi ko'rsatkichlari:
- xususiy kapitalning balans qiymati ko'rsatkichlari:
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning kapitalga nisbati Athira Pharma, Inc.|ATHA - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati athira.com|ATHA - Kompaniyaning umumiy qarzi|Qarzning balans kapitaliga nisbati Athira Pharma, Inc.|ATHA - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli kredit va qarzlari Athira Pharma|Oraliq qoplama koeffitsiyenti athira.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
Kompaniyaning umumiy tahlili:Athira Pharma Inc, ATHA
Moliyaviy barqarorlik Athira Pharma, Inc. (ATHA) uchun juda muhimdir, chunki kompaniya kognitiv buzilishlar uchun dori vositalarini ishlab chiqishda katalizatorlarni kutmoqda. Hozirgi uzoq muddatli qarzdorlikning kapitalga nisbati, 0.02 ga teng bo'lib, kompaniyaning muddati bir yildan ortiq bo'lgan tashqi qarzlarga bog'liqligini aks ettiradi. Ushbu ko'rsatkich uzoq muddatli majburiyatlarning aksiyadorlar kapitaliga nisbati sifatida hisoblanadi. Ushbu qiymatning kamayishi bankrotlik xavfini minimallashtiradi. Investorlar qarz yukining yo'qligi va soliq imtiyozlarining yo'qolishi o'rtasidagi muvozanatni baholashlari lozim.
Muhim raqobatchilar
Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi BIIB (Biogen Inc)|Uzoq muddatli qarzning kapitalga nisbati NBIX|RGC - Uzoq muddatli majburiyatlarning kapitalga nisbati|Axsome Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati acadia-pharm.com ACAD|XENE - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti VKTX (Viking Therapeutics Inc)|Supernus Pharma (SUPN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Catalyst Corp (CPRX)|DNLI (Denali Therapeutics) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati harmonybiosciences.com|Uzoq muddatli qarzning o'z kapitaliga nisbati BHVN (Biohaven)|Uzoq muddatli kreditlarning kapitalga nisbati AMLX|Uzoq muddatli qarzning kapitalga nisbati TRVI (Trevi Pharma)|Uzoq muddatli qarzning kapitalga koeffitsiyenti PRAX|Anavex Life Sciences - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati ceribell.com CBLL|Prothena Corp (PRTA) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Alector - Uzoq muddatli qarzning kapitalga koeffitsiyenti|ANNX (Annexon Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati Omeros Corp.|Uzoq muddatli qarzning o'z kapitaliga nisbati NGNE (Neurogene Inc.)|ACIU (acimmune.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Voyager Therapeutics, Inc. VYGR|NMRA (Neumora) - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Scilex Holding Co. - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti TVGN (Tevogen Bio Inc.)|ACOG: Uzoq muddatli qarzning kapitalga nisbati|cogrx.com (CGTX) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Inhibikase Therapeutics, Inc.|SAVA: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Assertio Holdings, Inc. (ASRT)|Uzoq muddatli qarzning o'z kapitaliga nisbati coyatherapeutics.com COYA|Uzoq muddatli qarzning kapitalga nisbati VTGN (Vistagen)|Uzoq muddatli qarzning kapitalga nisbati Ovid Therapeutics Inc OVID|ABOS: Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti CRVO (CervoMed, Inc.)|ATHE: Uzoq muddatli qarzning kapitalga nisbati|CLNN - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati PepGen Inc|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi JUNS (jupiterneurosciences.com)|Uzoq muddatli qarzning kapitalga nisbati RLMD|Uzoq muddatli qarzning o'z kapitaliga nisbati Annovis Bio Inc ANVS|Grace Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati Firefly Neuro (AIFF)|ANEW Medical, Inc. - Uzoq muddatli qarzning kapitalga nisbati|NRSN - Uzoq muddatli qarzning kapitalga nisbati|RVPH (Reviva Pharmaceuticals Holdings, Inc.) - Uzoq muddatli qarzning o'z kapitaliga nisbati|MTVA: Uzoq muddatli kreditlarning kapitalga nisbati|NRXS (NeurAxis, Inc) - Uzoq muddatli qarzning kapitalga nisbati|HSDT: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati PASG|Uzoq muddatli qarzning kapitalga nisbati bionomics.com.au (NEUP)|Uzoq muddatli qarzning o'z kapitaliga nisbati Minerva Neurosciences, Inc. NERV|ADXN: Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Alzamend - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Cyclerion Therapeutics|PTIX (protagenic.com) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Pasithea Therapeutics Corp. (KTTA) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Cortigent Inc|ATXI: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Brainstorm Cell Therapeutics, Inc. (BCLI)|CARA - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati CHRO (Chromocell Therapeutics)|Uzoq muddatli qarzning kapitalga nisbati Eliem Therapeutics, Inc. ELYM|ITCI: Uzoq muddatli qarzning o'z kapitaliga nisbati|Longboard Pharmaceuticals Inc - Uzoq muddatli kreditlarning kapitalga nisbati|MRNS: Uzoq muddatli qarzning kapitalga nisbati|NKGen Biotech Corp - Uzoq muddatli qarzning kapitalga koeffitsiyenti|NRBO (NeuroBo Pharmaceuticals) - Uzoq muddatli qarzning kapitalga nisbati|sagerx.com (SAGE) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Synaptogenix (SNPX)|TRVN (Trevena Inc.) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati VIGL (Vigil Neuroscience, Inc.)|Uzoq muddatli qarzning kapitalga nisbati Anew Medical Inc. WENA|CERE: Uzoq muddatli qarzning o'z kapitaliga nisbati